Symbiomix Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 06, 2015
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $41,000,000
Company Info
- Founding Year
- 2012
- Founders
- Klaus Veitinger
- Company Description
- Symbiomix Therapeutics is a privately-held biopharmaceutical company that offers anti-infective drug and single dose treatment.
- Market
- Women's health infections
- Location
- Newark, New Jersey, USA
- Coinvestors
- HBM Partners, OrbiMed Advisors